Bipolar disorder affects 40-50 million people globally, with genetic heritability between 60-80%, and can be triggered by both positive and negative life events, including promotions or new ...

Bipolar disorder is a complex psychiatric disorder, characterized by fluctuations between episodes of (hypo)mania and ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve overall quality of life. Learn more about the medication types, dosage, side ...

Bipolar disorder is a mental health condition marked by extreme mood swings, ranging from manic highs to depressive lows, ...

The final, formatted version of the article will be published soon. Background: Depressive disorders are highly prevalent among people with HIV (PWH) and are related to aberrant inflammation and ...

The NIH recommends treating the mood disorder first until the patient is “stabilized.” Stabilized is the key word here, particularly if the patient is suicidal, manic, or psychotic. “If depression is ...

Lithium is a mood stabilizer used to treat bipolar disorder, a condition that involves episodes of depression, mania, and hypomania. Lithium is used as an acute treatment for mood episodes and as a ...

we performed EEG microstate analysis in 19 patients with moderate to severe depression in bipolar affective disorder, depressive episode, and recurrent depressive disorder and in 19 healthy controls.

Older adults with major depressive disorder (MDD) demonstrate distinct and riskier driving behaviors than those without MDD, according to a study published online Dec. 30 in JAMA Network Open.

JNJ-18038683 is under clinical development by Johnson & Johnson and currently in Phase II for Bipolar Disorder (Manic Depression). According to GlobalData, Phase II drugs for Bipolar Disorder (Manic ...